Nasdaq Okyo News Today

LONDON and NEW YORK, April 08, 2024 (GLOBE NEWSWIRE) -- OKYO Pharma Limited (NASDAQ: OKYO), a clinical-stage biopharmaceutical company developing...

OKYO Pharma Limited (NASDAQ:OKYO – Get Free Report) saw a significant drop in short interest in March. As of March 15th, there was short interest totalling 50,800 shares, a drop of 21.4% from the February 29th total of 64,600 shares. Based on an average daily trading volume, of 183,100 shares, the short-interest ratio is presently […]

OKYO Pharma (NASDAQ:OKYO – Free Report) had its target price upped by HC Wainwright from $6.00 to $7.00 in a research note published on Friday morning, Benzinga reports. The firm currently has a buy rating on the stock. OKYO Pharma Stock Performance OKYO Pharma stock opened at $1.46 on Friday. OKYO Pharma has a 12 […]

OKYO Pharma Limited (NASDAQ:OKYO – Get Free Report) shares traded down 2.8% during mid-day trading on Monday . The stock traded as low as $1.50 and last traded at $1.54. 10,264 shares changed hands during trading, a decline of 89% from the average session volume of 89,761 shares. The stock had previously closed at $1.59. […]

OKYO Pharma Limited (NASDAQ:OKYO – Get Free Report) saw a significant decline in short interest during the month of October. As of October 31st, there was short interest totalling 78,100 shares, a decline of 35.6% from the October 15th total of 121,200 shares. Based on an average daily trading volume, of 258,000 shares, the days-to-cover […]

OKYO Pharma Limited (NASDAQ:OKYO – Get Free Report) was the target of a significant drop in short interest in the month of September. As of September 30th, there was short interest totalling 86,500 shares, a drop of 40.8% from the September 15th total of 146,000 shares. Currently, 0.5% of the shares of the company are […]

LONDON and NEW YORK, July 28, 2023 (GLOBE NEWSWIRE) -- OKYO Pharma Limited (Nasdaq: OKYO) (“OKYO” or the “Company”), an ophthalmology-focused...

NEW YORK, July 28, 2023 (GLOBE NEWSWIRE) -- OKYO Pharma Limited (Nasdaq: OKYO) ("OKYO" or the "Company"), an ophthalmology-focused bio-pharmaceutical...

OKYO Pharma Limited (NASDAQ:OKYO – Get Rating) was the target of a significant decline in short interest in May. As of May 31st, there was short interest totalling 65,900 shares, a decline of 22.8% from the May 15th total of 85,400 shares. Based on an average daily volume of 209,400 shares, the short-interest ratio is […]

OKYO Pharma Limited (NASDAQ:OKYO – Get Rating)’s share price shot up 6.1% on Thursday . The stock traded as high as $1.90 and last traded at $1.75. 15,825 shares traded hands during trading, a decline of 97% from the average session volume of 501,386 shares. The stock had previously closed at $1.65. OKYO Pharma Stock […]